drugset / Trial / NCT00213148

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

NCT00213148

Phase 2 Completed 271 enrolled EMD Serono
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor (anastrozole) versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction.

Timeline

Start
2005-03-10
Primary completion
2007-12-12
Completion
2007-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg Oral
Subject Anastrozole Other / unclassified 5 mg Oral
Subject Anastrozole Other / unclassified 10 mg Oral
Comparator Clomiphene Other / unclassified 50 mg Oral
Comparator Clomiphene Other / unclassified 100 mg Oral

Indications